Dosage immunoradiométrique du peptide natriurétique de type B (BNP) : étude analytique et clinique de la trousse IRMA BNP Cis bio international

Choy, 1994, Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods, Br Heart J, 72, 16, 10.1136/hrt.72.1.16 Clerico, 2000, Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods, Clin Chem, 46, 1529, 10.1093/clinchem/46.10.1529 Clerico, 1998, Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure, J Endocrinol Invest, 21, 170, 10.1007/BF03347297 Fleischer, 1997, Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnoea, N Z Med J, 110, 71 Gobinet-Georges, 2000, Stability of brain natriuretic peptide (BNP) in human whole blood and plasma, Clin Chem Lab M, 38, 519, 10.1515/CCLM.2000.076 Hittinger, 2002, Future molecules in heart failure, Presse M, 31, 33 Holmes, 1993, Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man, J Clin Endocrinol Metab, 76, 91, 10.1210/jc.76.1.91 Kjaer, 2001, Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives, Clin Physiol, 21, 661, 10.1046/j.1365-2281.2001.00371.x Mair, 1999, Natriuretic peptides in assessment of left-ventricular dysfunction, Scand J Clin Lab Invest Suppl, 230, 132, 10.3109/00365519909168337 Mair, 2001, The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure, Clin Chem Lab M, 39, 571 Morita, 1993, Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction, Circulation, 88, 82, 10.1161/01.CIR.88.1.82 Morrison, 2002, Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea, J Am Coll Cardiol, 39, 202, 10.1016/S0735-1097(01)01744-2 Nageh, 2002, Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patient's age, Ann Clin Biochem, 39, 151, 10.1258/0004563021901766 Sagnella, 2001, Measurement and importance of plasma brain natriuretic peptide and related peptides, Ann Clin Biochem, 38, 83, 10.1258/0004563011900317 Stein, 1998, Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease, Am Heart J, 135, 914, 10.1016/S0002-8703(98)70054-7 Sudoh, 1988, A new natriuretic peptide in porcine brain, Nature, 332, 78, 10.1038/332078a0 Valli, 2001, Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data, Clin Chim Acta, 306, 19, 10.1016/S0009-8981(01)00388-6 Valli, 1999, Review of 10 years of the clinical use of brain natriuretic peptide in cardiology, J Lab Clin M, 134, 437, 10.1016/S0022-2143(99)90163-4 Wallen, 1997, Brain natriuretic peptide in an elderly population, J Intern M, 242, 307, 10.1046/j.1365-2796.1997.00184.x